Scott Coleman
Signal active
Chief Development Officer
Contact Information
Social
Primary Organization
Xilio Therapeutics
Founded
2016
Employees
51-100
Industry
Biotechnology, Health Care, Biopharma, Therapeutics, Oncology
Bio
Scott Coleman is the Chief Development Officer of Xilio Therapeutics. He previously worked at Acceleron Pharma as a Vice President Nonclinical Development. Scott Coleman attended North Carolina State University.
Location
Lexington, Massachusetts, United States, North America
Jobs history
1
Xilio Therapeutics
Chief Development Officer
2023 - Current
Educations
1
N/A
Profile Resume
Scott Coleman is the Chief Development Officer at Xilio Therapeutics, based in United States, North America. With a background in Biotechnology, Scott Coleman has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.